Navigating the Longevity Market | Dr. Sue-Anne Toh - E718

"Aging is inevitable. It is a process. It's like a moving train. You can do something to halt the moving train, but realize you have to put a little bit of an effort. We will lose, after a certain age, 3 to 5% of our muscle mass every year if we don't do anything about it. So we have to then work 3 to 5% harder every year just to keep what we have."

"Perhaps in a big system like a big tanker ship, necessarily we move a lot slower, and I'm a lot more impatient. I decided maybe we try this as a little speedboat. That's high risk, but we could potentially move a lot faster, and in some ways still stay connected to the tanker ship."

"Singapore is actually the only country in the world that has launched a War on Diabetes in 2016. From a biological perspective, we know that Asians tend to develop complications of having excess fat, specifically visceral fat, at lower BMI thresholds. As a result, on the outside, we may not look obese or overweight, but we hide them really well, particularly around our waistline."

Dr. Sue-Anne Toh, CEO and co-founder of NOVI Health, joins Jeremy Au to discuss the critical intersection of metabolism, longevity, and health policy. They explore the "War on Diabetes" in Singapore, unpacking why Asian populations are predisposed to insulin resistance and visceral fat accumulation even at lower BMI levels. Dr. Toh shares her transition from healthcare administration at NUHS working with MOH, to launching a health-tech "speedboat" to bridge the implementation gap in preventive care. The conversation covers the 80/20 of longevity, the role of GLP-1 medications in hormonal balance, and actionable strategies for "banking" muscle mass to ensure quality of life during aging.

00:00 - Introduction: Dr. Sue-Anne Toh's background

02:14 - Choosing medicine over law: curiosity and impact

03:51 - From policy to founder: the "impatient" path to NOVI Health

10:49 - Navigating the "Snake Oil" noise in longevity

12:39 - The 80/20 of health span: sleep, steps, and nutrition

22:30 - The ROI of treats: behavior change vs. restrictions

30:02 - TOFI Phenotype: Thin Outside, Fat Inside

33:04 - The Insulin Resistance "Pancreas Factory"

37:56 - Public Health strategies: Enforce, Empower, Educate

40:35 - GLP-1s and the future of weight care

45:01 - Why muscle mass is the ultimate longevity asset

Watch on YouTube: https://www.youtube.com/watch?v=pP0L_qhSRJA&list=PLl9u6ECOP8_7scb97PE3whKu4yJVizIOd

Listen on Spotify: https://open.spotify.com/episode/5VkT4ttDZ9QfFQ0MDzkCxj

Keywords: Longevity and Healthspan, Asian Diabetes (TOFI), Preventive Healthcare Singapore, Continuous Glucose Monitors (CGM), GLP-1 Adoption Asia, Muscle Mass Preservation, Biohacking Risks